Cardio vascular risk profile among diabetic patients attending a tertiary care hospital in Odisha, India

Authors

  • Shubhransu Patro Department of General Medicine, Kalinga Institute of Medical Sciences, K. I. I. T Deemed to be University, Bhubaneswar, Odisha, India http://orcid.org/0000-0002-3597-4302
  • Sushant Kande Department of General Medicine, Kalinga Institute of Medical Sciences, K. I. I. T Deemed to be University, Bhubaneswar, Odisha, India
  • Dandi Suryanarayana Deo Department of General Medicine, Kalinga Institute of Medical Sciences, K. I. I. T Deemed to be University, Bhubaneswar, Odisha, India
  • Debasis Pathi Department of General Medicine, Kalinga Institute of Medical Sciences, K. I. I. T Deemed to be University, Bhubaneswar, Odisha, India
  • Sidharth Arora Department of General Medicine, Kalinga Institute of Medical Sciences, K. I. I. T Deemed to be University, Bhubaneswar, Odisha, India
  • Swastik Acharya Department of General Medicine, Kalinga Institute of Medical Sciences, K. I. I. T Deemed to be University, Bhubaneswar, Odisha, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20191162

Keywords:

Cardiovascular, Dyslipidaemia, Diabetes, Hypertension

Abstract

Background: Diabetes is associated with reduced quality of life and wide range of complications including CVD which vary geographically. The likely causes for the dramatic increase in the CVD rates include lifestyle changes associated with urbanization and the epidemiologic as well as nutritional transitions that are associated with economic development. This study aims to identify the CVD risk factors that exists among the diabetes patients of Odisha.

Methods: The study was conducted in KIMS during July-December 2016. A total of 300 diabetic and 300 non-diabetic patients were included in the study. Medical history and lifestyle data were collected using a pretested structured format and a separate checklist for laboratory results. Patient interview, physical examination and laboratory analysis were performed. Chi-square test was performed to identify significance of difference between prevalence of risk factors between diabetic and non-diabetic groups. Multiple logistic regression analyses (forward stepwise addition) were performed to identify the variables significantly associated with CVD risk factors. Significance level of 5% was considered.

Results: Total 376 males and 224 females were enrolled in the study with higher proportion of male participants in both diabetic and non-diabetic groups. Overall mean age of study subjects was 47.5±10.4 years. No significant difference was observed for demographic distribution between both groups. Prevalence of dyslipidaemia among diabetic patients was 86%, while prevalence of hypertension and dyslipidaemia were 71% and 62.3% respectively.

Conclusions: Overall prevalence of CVD risk factors observed in this study among population of Odisha, is higher compared to reported prevalence for other regions of India.

References

Sayadah SH, Fradkin J, Courie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc. 2004;291:335-42.

International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.

Zargar AH, Wani AI, Masoodi SR, Laway BA, Bashir MI. Mortality in diabetes mellitus-data from a developing region of the world. Diabetes Res Clin Pract. 1999;43:67-74.

Powers C. Chapter. Diabetes Mellitus. In: Fauci S, Braunwald E, Kasper L, Hauser L, Longo D, Jameson L and Loscalzo J eds Harrison’s Principles of Internal Medicine. 17th ed. McGraw Hill Medical Publishing Division, New York; 2007:2152-2168.

The DCCT Research Group. Lipid and lipoprotein levels in patients with IDDM. Diabetes Control and Complication Trial experience. Diabetes Care. 1992;15(7):886-94.

Cooper GR, Myer GL, Smith SJ, Schlant RC. Blood lipid measurements, variations and practical utility. JAMA. 1992;267(12):1652-60.

US Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): Final report. Circulation. 2002;106:3143-54.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52.

Yadav D, Mishra M, Tiwari A, Bisen PS, Goswamy HM, Prasad GB. Prevalence of dyslipidemia and hypertension in Indian type 2 diabetic patients with metabolic syndrome and its clinical significance. Osong public health and research perspectives. 2014;5(3):169-75.

Parikh RM, Joshi SR, Menon PS, Shah NS. Prevalence and pattern of diabetic dyslipidemia in Indian type 2 diabetic patients. Diabetes and Metabolic Syndrome: Clin Res Reviews. 2010;4(1):10-2.

Tamiru S, Alemseged F. Risk factors for cardiovascular diseases among diabetic patients in southwest Ethiopia. Ethiopian J Health Sci. 2010;20(2).

Cowie C, Harris M. Physical and metabolic characteristics of persons with diabetes. In: National diabetes data group (NDDG), Diabetes in America, second edition. National diabetes information clearinghouse, Bethesda. 1995;117-64.

Hanefeld M, Koehler C, Gallo S, Benke I, Ott P. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: The Diabetes in Germany (DIG) study. Cardiovasc Diabetol. 2007;6:13-29.

Monami M, Marchionni N, Masotti G, Mannucci EI. IDF and ATP‐III definitions of metabolic syndrome in the prediction of all‐cause mortality in type 2 diabetic patients. Diabetes, Obesity Meta. 2007 May;9(3):350-3.

Downloads

Published

2019-03-25

Issue

Section

Original Research Articles